Abstract
Resting left ventricular function, myocardial viability and stress-induced ischemia showed their prognostic impact in the pre-echocardiographic era, when evaluated by different tools, i.e., radioisotopic techniques for ventricular function [2], fluo-rodeoxyglucose uptake for viability [3], and exercise electrocardiography [4] and myocardial scintigraphy [5] for inducible ischemia. Only echocardiography allowed all these pieces of information — previously scattered among several diagnostic techniques — to be put together in a synoptic way.
Identification of patients with known ischemic heart disease who are at low risk is imp or tanty first, because it is reassuring for the patient; second, because in such a group the prognostic accuracy of any diagnostic test becomes very low; third, because it is difficult to demonstrate that even the most aggressive treatments can increase life expectancy when the latter is not reduced appreciably A. Maseri [1]
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maseri A (1995) Determinants of prognosis: primary and secondary prevention. In: Maseri A (ed) Ischemic heart disease. Churchill Livingstone, London, pp 226–312
The Multicenter Postinfarction Research Group (1983) Risk stratification and survival after myocardial infarction. N Engl J Med 309:331–336
Di Carli MF, Davidson M, Little R, et al (1994) Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73:527–533
Gohlke H, Samek L, Betz P, et al (1983) Exercise testing provides additional prognostic information in angiographically defined subgroups of patients with coronary artery disease. Circulation 68:979–985
Ladenheim ML, Pollock BH, Rozanski A, et al (1986) Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 7:464–471
Volpi A, De Vita C, Franzosi MG, et al (1993) Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-2 Data Base. Circulation 88:416–429
Sicari R, Picano E, Landi P, et al (1997) Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol 29:254–260
Meluzin J, Cerny J, Freiich M, et al (1998) Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 32:912–920
Senior R, Kaul S, Lahiri A (1999) Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 33:1848–1854
Pasquet A, Robert A, D’Hondt AM, et al (1999) Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 100:141–148
Sicari R, Ripoli A, Picano E, et al, VIDA (Viability Identification with Dipyridamole Administration) Study Group (2001) The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction. Eur Heart J 22:837–842
Sicari R, Borges AC, Palagi C, et al (2002) The prognostic value of myocardial viability recognized by low dose dobutamine echocardiography in revascularized patients with chronic ischemic left ventricular dysfunction (abstract). Circulation [SuppIII]:349
Allman KC, Shaw LJ, Hachamovitch R, et al (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39:1151–1158
Alderman EL, Fisher LD, Litwin P, et al (1983) Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 68:785–795
Carlos ME, Smart SC, Wynsen JC, et al (1997) Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 95:1402–1410
Picano E, Sicari R, Landi P, et al (1998) Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 98:1078–1084
Picano E, Severi S, Michelassi C, et al (1989) Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. Circulation 80:450–457
Picano E, Landi P, Bolognese L, et al (1993) Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. Am J Med 95:608–618
Severi S, Picano E, Michelassi C, et al (1994) Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation 89:1160–1173
Sicari R, Pasanisi E, Venneri L, et al on behalf of the Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups (2003) Stress echo results predict mortality: a large scale multicenter prospective international study. J Am Coll Cardiol. 41:589–95
Cortigiani L, Dodi C, Paolini EA, et al (1998) Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 32:1975–1981
Picano E, Ostojic M, Sicari R, et al (1997) Dipyridamole stress echocardiography: state of the art 1996. EPIC (Echo Persantine International Cooperative) Study Group. Eur Heart J 18 [Suppl D]:D16–D23
Picano E, Pingitore A, Sicari R, et al (1995) Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. Echo Persantine International Cooperative (EPIC) Study Group. J Am Coll Cardiol 26:908–913
Varga A, Picano E, Cortigiani L, et al (1996) Does stress echocardiography predict the site of future myocardial infarction? A large-scale multicenter study. EPIC (Echo Persantine International Cooperative) and EDIC (Echo Dobutamine International Cooperative) Study Groups. J Am Coll Cardiol 28:45–51
Vilella A, Maggioni A, Vilella M et al (1995) Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data base. Lancet 346:523–529
Greco CA, Salustri A, Beccareccia F et al (1997) Prognostic value of dobutamine echocardiography early after uncomplicated acute myocardial infarction: a comparison with exercise electrocardiography. J Am Coll Cardiol 29:261–267
Desideri A, Bigi R, Suzzi GL et al (1999) Stress echocardiography and exercise electrocardiography for risk stratification after non-Q-wave uncomplicated myocardial infarction. Am J Cardiol 84:739–41
Sicari R, Landi P, Picano E, et al (2002) Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study. Eur Heart J 23:1030–1037
Butman SM (1991) What would I want to know if my dad had a heart attack? Good sense versus dollars and cents. J Am Coll Cardiol 18:1220–1222
Topol EJ, Ellis SG, Cosgrove DM, et al (1993) Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation 87:1489–1497
Rogers WS, Boulby LJ, Chandra NC, et al (1994) Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation 90:2103–2114
Ellis SG, Mooney MR, George BS, et al (1992) Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Stenoses (TOPS) Study Group. Circulation 86:1400–1406
Madsen JK, Grande P, Saunamaki K et al (1997) Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation 1997;96:748–55
Boden WE, O’Rourke RA, Crawford MH et al (1998) Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 338:1785–92
Barnett PG, Chen S, Boden WE et al (2002) Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Circulation 105:680–4
Smith SC Jr, Dove JT, Jacobs AK, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty (2001) ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines). J Am Coll Cardiol 37:2215–2239
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Picano, E. (2003). Prognosis. In: Stress Echocardiography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05096-5_21
Download citation
DOI: https://doi.org/10.1007/978-3-662-05096-5_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-05098-9
Online ISBN: 978-3-662-05096-5
eBook Packages: Springer Book Archive